Description
The Journal of Law and the Biosciences and the Stanford Center for Law and the Biosciences hosted the first annual Bio LawLapalooza Conference at Stanford Law School on April 20 and 21. This event provided a forum for people interested in Law and the Biosciences to gather, talk, and share insights, following the precedent of Patent Con, among other conferences.
Robin Feldman, UC Hastings - Regulatory Property: The New IP
Ana Rutschman, DePaul University (Fellow) - FDA as a Catalyst for Health Innovation: Reassessing Incentives in the Wake of Ebola and Zika
Matthew Herder, Dalhousie University, and Richard Gold (co-author, not present), McGill University - What More Can The State Do?: Retrospective and Prospective Studies of State Sponsored Vaccine & Drug Development
Craig Konnoth, University of Pennsylvania (Fellow) - Drug’s Other Side Effects
Patti Zettler, Georgia State University, Natalie Hemmerich (co-author, not present), Ohio State University, and Micah Berman (co-author, not present), Ohio State University - Closing the Regulatory Gap for Synthetic Nicotine
Comments, questions and answers